Book Value per Share: Relmada Therapeutics Inc (RLMD)
Relmada Therapeutics (RLMD) maintains high scientific authority in the treatment of major depressive disorders due to the potential of REL-1017. The book value per common share illustrates the strategic focus on developing rapid-acting antidepressants with a low risk of dependence, with the parameter reaching 1.94. The company is currently completing final clinical trials, preparing for the commercial launch of the drug in the US market.
relmada.com - analytical breakdowns and key metrics (RLMD)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:Relmada, RLMD
The psychiatric community's high level of confidence in Relmada Therapeutics (RLMD) developments in depression therapy builds long-term brand potential. The net asset dynamics reflected in the consolidated book value per share measure the actual value of the owner's stake minus liabilities, allowing investors to filter out market noise and assess the issuer's actual capital stability through the analysis of this chart.
Competitor analysis for Relmada Therapeutics
BIIB: Net Assets per Single Share|NBIX - Accounting Value per Share|Book Value per Share Regencell Bioscience|AXSM (axsome.com) - Equity per Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|TRVI (Trevi Corp) - Net Asset Value per Share|PRAX - Net Assets per Single Share|Accounting Value of a Share anavex.com|CeriBell - Book Value per Share|Net Asset Value per Share PRTA (Prothena Corporation)|Net Assets per Single Share Alector ALEC|Annexon Biosciences Inc. - Net Assets per Single Share|OMER: Net Assets per Single Share|NGNE - Accounting Value per Share|ACIU: Book Value per Share|Voyager Therapeutics Inc (VYGR) - Book Value per Share|Book Value per Share Neumora Therapeutics Inc (NMRA)|Equity per Share Scilex Holding Company, Inc.|Book Value per Share TVGN|Book Value per Share alphacognition.com ACOG|Accounting Value per Share Cognition Therapeutics|IKT - Accounting Value of a Share|Accounting Value per Share Cassava SAVA|ASRT - Book Price of a Share|Book Value per Share coyatherapeutics.com COYA|Vistagen (VTGN) - Accounting Value of a Share|Book Value per Share OVID (Ovid Therapeutics Inc)|Net Asset Value per Share ABOS|CervoMed Inc (CRVO) - Net Assets per Single Share|Accounting Value of a Share alteritytherapeutics.com (ATHE)|Book Value per Share CLNN (Clene)|PepGen Inc - Book Value per Share|Net Assets per Single Share Jupiter Neurosciences Inc|ANVS - Share Book Value|Book Value per Share GRCE|Net Asset Value per Share Firefly Neuro|KLTO (ANEW Medical) - Accounting Value per Share|Book Value per Share NeuroSense Therapeutics, Ltd. (NRSN)|Accounting Value per Share Reviva Pharmaceuticals Holdings, Inc.|Book Price of a Share metaviatx.com (MTVA)|Book Value per Share NRXS|Net Assets per Share Helius Medical Technologies, Inc. HSDT|PASG: Book Value per Share|NEUP: Accounting Value per Share|Minerva Neurosciences, Inc. - Net Assets per Single Share|ATHA (Athira Pharma Inc) - Net Assets per Share|ADXN - Net Assets per Single Share|Accounting Value of a Share ALZN|Net Assets per Single Share Cyclerion Therapeutics (CYCN)|Net Assets per Single Share PTIX (protagenic.com)|Pasithea Therapeutics Corp. - Net Assets per Single Share|Accounting Value per Share Cortigent Inc CRGT|Avenue Therapeutics, Inc (ATXI) - Book Value per Share|BCLI: Equity per Share|Net Assets per Single Share Cara Therapeutics, Inc.|chromocell.com (CHRO) - Equity per Share|Book Value per Share ELYM (Eliem Therapeutics, Inc.)|Net Asset Value per Share Intra-Cellular (ITCI)|Accounting Value per Share LBPH|Book Value per Share MRNS (Marinus Pharma)|Net Assets per Single Share NKGen Biotech, Inc.|neurobopharma.com - Accounting Value of a Share|SAGE (Sage Therapeutics) - Net Assets per Single Share|SNPX: Net Asset Value per Share|Net Assets per Single Share Trevena, Inc TRVN|Vigil Neuroscience, Inc. (VIGL) - Accounting Value of a Share|Book Value per Share WENA (Anew Medical)|Net Asset Value per Share CERE